AC Immune SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by AC Immune SA for the month of June 2022. The filing was submitted on June 16, 2022, and is signed by CEO Andrea Pfeifer and CFO Joerg Hornstein. The registrant files annual reports under Form 20-F.
Financial Metrics
The provided filing text does not contain specific financial data. It serves as a cover document referencing an external press release (Exhibit 99.1) but does not disclose revenue, profit, cash flow, margins, debt, or liquidity figures within this text.
Material Changes
The filing text does not provide details on material changes versus prior periods. The content is limited to the cover page and exhibit index.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in this specific text. The filing references a press release dated June 16, 2022, which likely contains these details, but the text of that release is not included here.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Press Release dated June 16, 2022) for the actual announcement details.
- Confirm the company's headquarters location in Lausanne, Switzerland.
- Note that this filing is a procedural submission to the SEC and does not contain standalone financial statements.